UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Recruitment status Completed
Unique ID issued by UMIN UMIN000012440
Receipt No. R000014555
Official scientific title of the study The response of pituitary hormones to growth hormone-releasing peptide-2 (GHRP-2)
Date of disclosure of the study information 2013/11/29
Last modified on 2013/11/29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The response of pituitary hormones to growth hormone-releasing peptide-2 (GHRP-2)
Title of the study (Brief title) The response of pituitary hormones to growth hormone-releasing peptide-2 (GHRP-2)
Region
Japan

Condition
Condition Adult
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The response of the pituitary hormones to a single dose (100 µg) of GHRP-2 administration in the healthy individuals.
Basic objectives2 Bio-equivalence
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The response of the pituitary hormones to a single dose (100 µg) of GHRP-2 administration
Key secondary outcomes

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Medicine
Interventions/Control_1 administration of GHRP-2
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria healty adult
Key exclusion criteria A person who cannot makes decision
Target sample size 20

Research contact person
Name of lead principal investigator Toshiaki Hanafusa
Organization Osaka medical college
Division name Department of Internal Medicine (I)
Address 2-7 Daigaku-machi, Takatsuki city, Osaka 569-8686, Japan.
TEL 072-683-1221
Email hanafusa@poh.osaka-med.ac.jp

Public contact
Name of contact person Keiji Tanimoto
Organization Osaka medical college
Division name Department of Internal Medicine (I)
Address 2-7 Daigaku-machi, Takatsuki city, Osaka 569-8686, Japan.
TEL 072-683-1221
Homepage URL
Email in1120@poh.osaka-med.ac.jp

Sponsor
Institute Department of Internal Medicine (I), Osaka medical college
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 11 Month 29 Day

Progress
Recruitment status Completed
Date of protocol fixation
2010 Year 01 Month 18 Day
Anticipated trial start date
2010 Year 01 Month 18 Day
Last follow-up date
Date of closure to data entry
2012 Year 03 Month 31 Day
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information

Management information
Registered date
2013 Year 11 Month 29 Day
Last modified on
2013 Year 11 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014555


Contact us.